Schistosomiasis does not affect the outcome of HCV infection in genotype 4-infected patients.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Tropical Medicine and Hygiene

• Publication date

  2014-05-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4269/ajtmh.13-0703PMID 24615138PMCID PMC4015572
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis C virus infection

  2015cited by this paper
• Incidence of hepatitis C virus infection among Egyptian healthcare workers at high risk of infection.

  2013cited by this paper
• HCV burden of infection in Egypt: results from a nationwide survey

  2012cited by this paper
• Risk factors for hepatitis C virus infection among Egyptian healthcare workers in a national liver diseases referral centre.

  2012cited by this paper
• Hepatitis C Virus-Multispecific T-Cell Responses without Viremia or Seroconversion among Egyptian Health Care Workers at High Risk of Infection

  2012cited by this paper
• From host immunity to pathogen invasion: the effects of helminth coinfection on the dynamics of microparasites.

  2011cited by this paper
• Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment

  2011cited by this paper
• Hepatocellular carcinoma in Hepatitis C genotype 4 after viral clearance and in absence of cirrhosis: two case reports

  2009cited by this paper
• Influence of extrahepatic viral infection on the natural history of hepatitis C.

  2008cited by this paper
• Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors.

  2008cited by this paper
• Soluble egg antigen of Schistosoma Haematobium induces HCV replication in PBMC from patients with chronic HCV infection

  2006cited by this paper
• Progression of fibrosis in hepatitis C with and without schistosomiasis: Correlation with serum markers of fibrosis

  2006cited by this paper
• Peginterferon α-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response

  2005cited by this paper
• Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion.

  2005cited by this paper
• Schistosoma infection inhibits cellular immune responses to core HCV peptides

  2005cited by this paper
• Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study

  2004cited by this paper
• Analysis of T cell responses against hepatitis C virus genotype 4 in Egypt.

  2004cited by this paper
• Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis.

  2004cited by this paper
• Role of hepatitis C infection in chronic liver disease in Egypt.

  2002cited by this paper
• Population-based differences in Schistosoma mansoni- and hepatitis C-induced disease.

  2002cited by this paper
• The immunobiology of schistosomiasis

  2002cited by this paper
• Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection

  2001cited by this paper
• The Role of Hepatitis C in Hepatocellular Carcinoma: A Case Control Study Among Egyptian Patients

  2001cited by this paper
• Cytokine responses to mitogen and Schistosoma haematobium antigens are different in children with distinct infection histories

  2001cited by this paper
• Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response.

  2001cited by this paper
• Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni.

  2001cited by this paper
• Hepatitis C virus infection.

  2001cited by this paper
• Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C

  2000cited by this paper
• Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus

  2000cited by this paper
• Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni.

  2000cited by this paper
• Hepatitis C virus (HCV) infection in a community in the nile delta: Population description and HCV prevalence

  2000cited by this paper
• The natural history of hepatitis C virus infection: host, viral, and environmental factors.

  2000cited by this paper
• Interferon therapy in patients with chronic hepatitis C and schistosomiasis.

  2000cited by this paper
• Cellular immune response to the hepatitis C virus

  1999cited by this paper
• Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence

  1999cited by this paper
• Chronic Japanese schistosomiasis and hepatocellular carcinoma: ten years of follow-up in Yamanashi Prefecture, Japan.

  1999cited by this paper
• Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.

  1999cited by this paper
• The natural history of hepatitis C—A quandary

  1998cited by this paper
• Role of cytokines in the formation and downregulation of hepatic circumoval granulomas and hepatic fibrosis in Schistosoma mansoni-infected mice.

  1998cited by this paper
• Recurrence of hepatitis C virus after loss of virus specific CD4+ T cell response in acute hepatitis C

  1998cited by this paper
• Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections.

  1997cited by this paper
• New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a

  1997cited by this paper
• Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity.

  1996cited by this paper
• Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey

  1994cited by this paper
• Schistosomiasis as an important determining factor for the response of Egyptian patients with chronic hepatitis C to therapy with recombinant human alpha-2 interferon.

  1994cited by this paper
• Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni

  1991cited by this paper

• Evaluation of APRI Score-based hepatic fibrosis and cirrhosis among hepatitis C patients co-infected with schistosomiasis

  2025cites this paper
• The Global Prevalence of and Factors Associated with Parasitic Coinfection in People Living with Viruses: A Systematic Review and Meta-Analysis

  2025cites this paper
• Influence of intestinal schistosome and hepatitis B or C coinfection on hepatic disease: a systematic review and meta-analysis

  2025cites this paper
• Co-infections of Schistosoma spp. and malaria with hepatitis viruses from endemic countries: A systematic review and meta-analysis.

  2022cites this paper
• Host-Related Predictors of Persistence of Hepatitis C Virus Infection

  2019cites this paper
• Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions

  2018cites this paper
• Co-infection of Schistosoma mansoni/hepatitis C virus and their associated factors among adult individuals living in fishing villages, north-western Tanzania

  2017cites this paper
• Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.

  2016cites this paper
• Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection.

  2015cites this paper
• Schistosomiasis, hepatitis B and hepatitis C co-infection

  2015cites this paper
• Hepatitis B virus seropositivity among schistosomiasis and diabetes mellitus patients in Sana'a City, Yemen.

  2014cites this paper